- Report
- November 2023
- 150 Pages
Global
From €4225EUR$4,450USD£3,563GBP
- Report
- July 2023
- 117 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- July 2023
- 119 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- January 2024
- 182 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- September 2021
- 189 Pages
Global
From €4225EUR$4,450USD£3,563GBP
- Report
- June 2023
- 83 Pages
Global
From €3500EUR$3,949USD£3,056GBP
- Report
- January 2025
- 132 Pages
Global
From €902EUR$950USD£761GBP
The Drug Discovery Services market is a subset of the pharmaceutical industry that focuses on the development of new drugs. It involves the identification of potential drug targets, the design and synthesis of drug candidates, and the testing of these candidates for efficacy and safety. Drug discovery services are typically provided by contract research organizations (CROs) and include a range of services such as target identification, lead optimization, preclinical and clinical development, and regulatory support.
The Drug Discovery Services market is driven by the need for new and improved treatments for a variety of diseases, as well as the increasing demand for personalized medicines. The market is also driven by advances in technology, such as artificial intelligence and machine learning, which have enabled the development of more efficient and cost-effective drug discovery processes.
Some of the major companies in the Drug Discovery Services market include Charles River Laboratories, PPD, Inc., WuXi AppTec, Evotec, and Syngene International. Show Less Read more